Brahmi Ghee (Brahmi Ghrita)

About

What it is and where it shows up.

Brahmi Ghee (Brahmi Ghrita) is a traditional Ayurvedic medicated clarified butter prepared by infusing the herb Bacopa monnieri (brahmi) — along with adjunct herbs such as Vacha, Shankhapushpi, and Kushtha — into cow's ghee (Go-Ghrita) using classical sneha-paka processing. It is used in Ayurvedic practice as a nootropic, nervine tonic, and vehicle for brain-targeting botanical actives, leveraging ghee's lipophilic properties to facilitate blood-brain barrier penetration.

Safety summary

The regulatory and scientific consensus.

Bacopa monnieri has a high therapeutic index and is generally well-tolerated in adults; the most common adverse effects are gastrointestinal (nausea, increased stool frequency, abdominal cramps). Ghee, its fat base, is a saturated-fat-rich dairy product that may raise serum triglycerides and total cholesterol at high dietary levels in genetically predisposed individuals. No formal ADI has been established for Brahmi Ghrita as a composite formulation by FSSAI, EFSA, FDA, or WHO; it is governed in India as an Ayurvedic proprietary medicine under the Drugs and Cosmetics Act and, when marketed as a food supplement, under FSSAI's Health Supplements & Nutraceuticals Regulations 2016.

Regulatory landscape

What food-safety regulators have decided.

Jurisdiction	Status	Note
FDA (Food and Drug Administration) (United States)	Restricted	Bacopa monnieri is not approved by the FDA for any medical purpose. In 2019, FDA issued warning letters to manufacturers making therapeutic claims about Bacopa-containing products. Brahmi Ghee as a composite product has no GRAS (Generally Recognized as Safe) designation; ghee itself is recognised as a dairy-derived fat requiring milk allergen labelling under 21 CFR / FD&C Act. Bacopa monnieri may be sold as a dietary supplement ingredient but no therapeutic claims are permitted.source
FSSAI (Food Safety and Standards Authority of India) (India)	Approved	Bacopa monnieri is listed as a permitted botanical ingredient under FSSAI Health Supplements, Nutraceuticals, and Functional Food Regulations 2016. When the formulation is positioned as an Ayurvedic medicine (classical formulation), it falls under the Drugs and Cosmetics Act 1940 regulated by Ministry of AYUSH; as a food supplement it requires FSSAI licensing and prior approval for any specific health claims. No maximum daily intake is formally codified for the composite ghrita formulation.source
EFSA (European Food Safety Authority) (European Union)	Under_review	Brahmi Ghrita / Bacopa monnieri has not received a formal EFSA safety opinion or authorised health claim under Regulation (EC) No 1924/2006. Botanicals used as food supplements in the EU remain under national competence pending a harmonised framework; no Article 13 health claim for Bacopa monnieri has been approved. Ghee, the fat base, is a standard dairy fat regulated under EU dairy product rules.source

Who should approach with care

Whose guidance would steer them away.

Pregnancy — Bacopa monnieri lacks adequate controlled safety data in pregnancy; the herb's pharmacological activity on the CNS and absence of gestational safety studies warrant medical consultation before use.

Lactation — No established safety profile for Bacopa monnieri or medicated ghee preparations during breastfeeding; constituents such as triterpenoid saponins (bacosides) could theoretically transfer into breast milk.

Infants — Classical Ayurvedic texts do not recommend full-dose Brahmi Ghrita for infants without specialist Ayurvedic/medical supervision; the ghee base and herbal alkaloids are not appropriate for unsupervised infant use.

Children — Bacopa monnieri may be used in children (6–12 years) at reduced doses (up to 225 mg/day for up to 6 months per clinical data), but the composite Brahmi Ghrita formulation should only be given under qualified medical or Ayurvedic practitioner advice.

Heart Disease — The ghee base is rich in saturated fatty acids and cholesterol; high intake may raise serum triglycerides and total cholesterol in individuals with a genetic predisposition to cardiovascular disease, as shown in animal studies.

Research citations

The sources behind this verdict.

1PubMed. Bacopa monnieri – StatPearls (NCBI Bookshelf), 2023. ncbi.nlm.nih.gov
2PubMed. The Ayurvedic plant Bacopa monnieri inhibits inflammatory pathways in the brain, 2017. pmc.ncbi.nlm.nih.gov
3FSSAI. Food Safety and Standards (Health Supplements, Nutraceuticals, Food for Special Dietary Use, Functional Food and Novel Food) Regulations, 2016, 2016. fssai.gov.in
4PubMed. Analytical profile of Brahmi Ghrita: A polyherbal Ayurvedic formulation, 2013. pmc.ncbi.nlm.nih.gov
5PubMed. The effect of ghee (clarified butter) on serum lipid levels and microsomal lipid peroxidation, 2011. pmc.ncbi.nlm.nih.gov

Independently researched5 citations